Thyrocare Technologies Limited (THYROCARE.BO)
INR 980.85
(-1.19%)
INR 980.85
(-1.19%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 24.5 Million INR | -55.78% |
| 2022 | 55.4 Million INR | -21.64% |
| 2021 | 70.7 Million INR | 250.11% |
| 2020 | -47.1 Million INR | -225.94% |
| 2019 | 37.4 Million INR | 255.19% |
| 2018 | -24.1 Million INR | 75.46% |
| 2017 | -98.2 Million INR | -272.82% |
| 2016 | -26.34 Million INR | 36.3% |
| 2015 | -41.35 Million INR | 18.52% |
| 2014 | -50.75 Million INR | -138.75% |
| 2013 | 130.98 Million INR | 75.34% |
| 2012 | 74.7 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.79 Billion INR | 7245.31% |
| 2024 Q2 | -456.1 Million INR | -115.1% |
| 2023 Q1 | 1.4 Billion INR | 2428.34% |
| 2023 Q3 | 993.4 Million INR | 207.08% |
| 2023 Q2 | 323.5 Million INR | -76.9% |
| 2023 FY | 24.5 Million INR | -55.78% |
| 2023 Q4 | 24.5 Million INR | -97.53% |
| 2022 Q3 | 118.6 Million INR | 639.09% |
| 2022 Q1 | 1.38 Billion INR | 1863.79% |
| 2022 Q2 | -22 Million INR | -101.58% |
| 2022 FY | 55.4 Million INR | -21.64% |
| 2022 Q4 | 55.4 Million INR | -53.29% |
| 2021 Q4 | 70.7 Million INR | -52.23% |
| 2021 FY | 70.7 Million INR | 250.11% |
| 2021 Q2 | 166.5 Million INR | 179.67% |
| 2021 Q1 | -209 Million INR | -343.74% |
| 2021 Q3 | 148 Million INR | -11.11% |
| 2020 Q2 | 61.7 Million INR | -92.3% |
| 2020 Q1 | 801 Million INR | 2041.71% |
| 2020 Q3 | 880.29 Million INR | 1326.74% |
| 2020 Q4 | -47.1 Million INR | -105.35% |
| 2020 FY | -47.1 Million INR | -225.94% |
| 2019 Q1 | 842.4 Million INR | 3595.44% |
| 2019 FY | 37.4 Million INR | 255.19% |
| 2019 Q4 | 37.4 Million INR | -91.46% |
| 2019 Q2 | -73.4 Million INR | -108.71% |
| 2019 Q3 | 438 Million INR | 696.73% |
| 2018 Q2 | -146 Million INR | -113.04% |
| 2018 FY | -24.1 Million INR | 75.46% |
| 2018 Q1 | 1.11 Billion INR | 1240.07% |
| 2018 Q4 | -24.1 Million INR | -102.73% |
| 2018 Q3 | 882.4 Million INR | 704.38% |
| 2017 Q2 | 10.52 Million INR | -99.07% |
| 2017 Q3 | 1.36 Billion INR | 12896.58% |
| 2017 Q4 | -98.2 Million INR | -107.18% |
| 2017 FY | -98.2 Million INR | -272.82% |
| 2017 Q1 | 1.13 Billion INR | 4392.71% |
| 2016 Q3 | 1.17 Billion INR | 1204.52% |
| 2016 Q2 | -106.79 Million INR | -110.48% |
| 2016 Q1 | 1.01 Billion INR | 2564.96% |
| 2016 FY | -26.34 Million INR | 36.3% |
| 2016 Q4 | -26.34 Million INR | -102.23% |
| 2015 Q3 | -68.17 Million INR | 54.34% |
| 2015 Q1 | 893.76 Million INR | 0.0% |
| 2015 FY | -41.35 Million INR | 18.52% |
| 2015 Q4 | -41.35 Million INR | 39.34% |
| 2015 Q2 | -149.3 Million INR | -116.7% |
| 2014 FY | -50.75 Million INR | -138.75% |
| 2013 FY | 130.98 Million INR | 75.34% |
| 2012 FY | 74.7 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 1.06 Billion INR | 97.694% |
| Dr. Lal PathLabs Limited | -5.83 Billion INR | 100.42% |
| Metropolis Healthcare Limited | 1.25 Billion INR | 98.053% |
| Vijaya Diagnostic Centre Limited | 1.86 Billion INR | 98.684% |
| Vimta Labs Limited | -66 Million INR | 137.121% |